Macroaxis does not monitor all media channels or aggregates social signals for Natus Medical. But even though we do not provide professional-grade financial sentiment analysis on Natus Medical Incorp, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for Natus Medical. Check also Natus Medical Hype Analysis, Natus Medical Correlation and Natus Medical Performance
Natus Medical Incorporated provides newborn care and neurology healthcare services and products worldwide. The company has market cap of 862.62 million. It offers services and products used for the screening, diagnosis, detection, treatment ...
Traders may be interested in various technical levels on shares of Natus Medical Inc . After a recent check, the Williams percentR was spotted at -97.00.
In recent trading day Natus Medical Incorporated stock showed the move of -0.17 percent with the closing price of 28.95. Closing price generally refers to the last price at which a stock trades during a regular trading session.
Shares of Natus Medical Inc have seen the Mesa Adaptive Moving Average crawl below the Fractional Moving Average or FAMA.
After having 0.40 EPS previously, Natus Medical Incorporated analysts see 75.00 percent EPS growth. The stock decreased 0.17 percent or 0.05 during the last trading session, reaching 28.95.
As close of Thursday trade, Natus Medical Incorporated is standing at value of 29.00 with the rising stream of 1.40.
Natus Medical Incorporated stock price distance from twenty day simple moving average slumped at -24.32 percent while its distance from fifty day simple moving average declined -27.29 percent along with -22.87 percent below distance from two hundred simple moving ...
The company announced its last quarter financial performance results on 10252017. Natus Medical Inc. belongs to Medical sector that declined -4.61 percent in value when last trading session closed at 29.
Filed transaction by Natus Medical Inc director. Grant, award or other acquisition pursuant to Rule 16b-3
GlobeNewswire - Jan 8, 2018 PLEASANTON, Calif., Jan. 08, 2018 -- Natus Medical Incorporated today announced its financial guidance for the first quarter and full year 2018.
Filed transaction by Natus Medical Inc director. General open market or private sale of non-derivative or derivative security
4.Employee Benefits. During the Employment Term, Executive will be entitled to participate in the employee benefit plans currently and hereafter maintained by the Company of general applicability to other employees of the Company, including, without ...
Filed transaction by Natus Medical Inc officer. Unconventional Insider trading
Filed transaction by Natus Medical Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Natus Medical Inc currently has a 14-day Commodity Channel Index of -45.34. Active investors may choose to use this technical indicator as a stock evaluation tool.